Michael E Abel, MD
General Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
Offices
2 locations · San Francisco Surgical · 5 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Abel’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G38707 · Current
Licensed to practise in California · since 1979 · expires 2028-08-31 · Case Western Reserve University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- San Francisco Endoscopy Center, A CPMC AffiliateAmbulatory Surgery Center · San Francisco, CAOwner · accredited by JCAccreditation Renewed1 inspection, 1 with deficiencies · last 2013-06-26: Requirements Met
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$173,383
Medicare paid this office $173,383 for 475 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection of hemorrhoid | 37 | $16,348 | $308 |
| New patient visit (45+ min) | 81 | $11,397 | $141 |
| Removal of external hemorrhoids by rubber banding | 22 | $9,631 | $268 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 42 | $8,539 | $203 |
| Short return visit (20+ min) | 78 | $8,026 | $82 |
See all 17 services
| Injection of hemorrhoid | 37 | $16,348 | $308 |
| New patient visit (45+ min) | 81 | $11,397 | $141 |
| Removal of external hemorrhoids by rubber banding | 22 | $9,631 | $268 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 42 | $8,539 | $203 |
| Short return visit (20+ min) | 78 | $8,026 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $6,186 | $155 |
| Repair of groin hernia (5 years or older) | 13 | $6,125 | $471 |
| Diagnostic exam of anus using an endoscope | 44 | $6,082 | $113 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 29 | $5,965 | $206 |
| Removal of gallbladder using an endoscope | 11 | $5,929 | $539 |
| Return visit (30+ min) | 40 | $5,508 | $122 |
| Biopsy of large bowel using a flexible endoscope | 39 | $5,172 | $133 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 20 | $4,323 | $216 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $3,876 | $70 |
| New patient visit (30+ min) | 41 | $3,692 | $90 |
| New patient visit (60+ min) | 12 | $2,101 | $175 |
| Short return visit | 21 | $1,288 | $54 |
Procedures Medicare counted
| Colonoscopy | 118 | More than 83% of doctors who do this |
| Hernia repair - groin (open) | 19 | More than 96% of doctors who do this |
| Hernia repair (minimally invasive) | 1-10 | None |
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
475 Original Medicare patients in 2024. Average age 76 · Under 65 4% · 85 and older 14% · Women 46% · Also on Medicaid 25% · Health risk score 1.21. At or below the middle of the specialty; the typical general surgery clinician is at 1.69.
Conditions among them: High blood pressure 70% · Diabetes 26% · Coronary heart disease 25% · Cancer 22% · Chronic kidney disease 20% · Atrial fibrillation 19% · Depression 19% · Heart failure 12% · COPD 11% · Dementia 7% · Stroke 5%.
The office billed $494,036, Medicare allowed $221,333 and paid $173,383; for 853 services of 78 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 475 | 853 | 76 | 1.21 | $494,036 | $173,383 |
| 2023 | 494 | 871 | 75 | 1.20 | $521,798 | $183,755 |
| 2022 | 542 | 921 | 75 | 1.15 | $565,079 | $205,180 |
| 2021 | 482 | 818 | 75 | 1.17 | $517,770 | $184,150 |
| 2020 | 446 | 770 | 74 | 1.30 | $470,176 | $156,989 |
| 2019 | 523 | 879 | 76 | 1.45 | $577,098 | $200,000 |
| 2018 | 579 | 1,122 | 74 | 1.30 | $689,683 | $225,906 |
| 2017 | 552 | 1,082 | 74 | 1.46 | $621,743 | $214,867 |
| 2016 | 587 | 1,219 | 75 | 1.45 | $740,897 | $241,009 |
| 2015 | 616 | 1,175 | 74 | 1.33 | $672,978 | $229,222 |
| 2014 | 548 | 1,042 | 74 | 1.30 | $624,996 | $213,208 |
| 2013 | 546 | 1,015 | 74 | 1.33 | $622,071 | $213,917 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Injection of hemorrhoid | 51 | $22,848 | $301 |
| Removal of external hemorrhoids by rubber banding | 23 | $10,705 | $261 |
| New patient visit (45+ min) | 67 | $9,212 | $137 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 40 | $8,120 | $203 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $7,597 | $149 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 34 | $6,897 | $203 |
| Repair of groin hernia (5 years or older) | 15 | $6,775 | $452 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $6,243 | $70 |
| Diagnostic exam of anus using an endoscope | 57 | $6,072 | $105 |
| Short return visit (20+ min) | 60 | $5,428 | $73 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 25 | $5,278 | $211 |
| Removal of gallbladder using an endoscope | 11 | $4,896 | $445 |
| New patient visit (60+ min) | 21 | $4,268 | $203 |
| Biopsy of large bowel using a flexible endoscope | 33 | $3,704 | $112 |
| New patient visit (30+ min) | 40 | $3,427 | $86 |
| Return visit (30+ min) | 27 | $3,362 | $116 |
| Short return visit | 18 | $980 | $52 |
2022: 15 services
| Injection of hemorrhoid | 57 | $26,637 | $321 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $9,462 | $172 |
| New patient visit (30+ min) | 101 | $8,657 | $86 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 41 | $8,335 | $203 |
| Removal of gallbladder using an endoscope | 15 | $8,274 | $552 |
| Diagnostic exam of anus using an endoscope | 67 | $7,776 | $104 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 32 | $6,468 | $202 |
| Removal of external hemorrhoids by rubber banding | 15 | $5,736 | $273 |
| Biopsy of large bowel using a flexible endoscope | 41 | $5,526 | $135 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $5,029 | $62 |
| Short return visit (20+ min) | 53 | $3,572 | $67 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 17 | $3,189 | $188 |
| New patient visit (45+ min) | 16 | $2,067 | $129 |
| Short return visit | 41 | $2,004 | $43 |
| New patient visit (15+ min) | 16 | $571 | $36 |
2021: 14 services
| Injection of hemorrhoid | 50 | $25,315 | $320 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 38 | $7,953 | $209 |
| New patient visit (30+ min) | 86 | $7,664 | $89 |
| New patient visit (45+ min) | 49 | $7,271 | $148 |
| Removal of external hemorrhoids by rubber banding | 13 | $6,996 | $280 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,570 | $173 |
| Biopsy of large bowel using a flexible endoscope | 46 | $6,139 | $133 |
| Removal of gallbladder using an endoscope | 12 | $5,975 | $498 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 30 | $5,948 | $198 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 28 | $5,865 | $209 |
| Short return visit (20+ min) | 64 | $5,665 | $76 |
| Diagnostic exam of anus using an endoscope | 38 | $5,428 | $121 |
| Short return visit | 52 | $2,777 | $48 |
| Emergency department visit with moderate level of medical decision making | 14 | $1,408 | $101 |
2020: 14 services
| Injection of hemorrhoid | 56 | $22,752 | $284 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $10,370 | $182 |
| New patient visit (30+ min) | 108 | $8,737 | $81 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 36 | $7,734 | $215 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 29 | $6,683 | $230 |
| Biopsy of large bowel using a flexible endoscope | 52 | $5,626 | $108 |
| Short return visit (20+ min) | 63 | $4,407 | $59 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $3,966 | $209 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $3,304 | $60 |
| Removal of external hemorrhoids by rubber banding | 11 | $3,108 | $239 |
| Diagnostic exam of anus using an endoscope | 26 | $3,047 | $102 |
| New patient visit (45+ min) | 18 | $2,586 | $144 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,494 | $119 |
| Short return visit | 21 | $1,005 | $35 |
2019: 17 services
| Injection of hemorrhoid | 50 | $18,662 | $274 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $10,205 | $179 |
| New patient visit (30+ min) | 103 | $9,048 | $88 |
| Removal of gallbladder using an endoscope | 15 | $8,294 | $553 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 34 | $7,146 | $210 |
| Repair of groin hernia (5 years or older) | 16 | $7,068 | $442 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 30 | $6,510 | $210 |
| New patient visit (45+ min) | 43 | $6,114 | $142 |
| Biopsy of large bowel using a flexible endoscope | 43 | $5,889 | $137 |
| Short return visit (20+ min) | 75 | $5,598 | $63 |
| Removal of external hemorrhoids by rubber banding | 12 | $4,899 | $258 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 24 | $4,843 | $202 |
| Diagnostic exam of anus using an endoscope | 37 | $3,744 | $87 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,290 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,228 | $62 |
| Short return visit | 35 | $1,361 | $37 |
| Return visit (30+ min) | 15 | $1,342 | $89 |
2018: 16 services
| Injection of hemorrhoid | 51 | $13,399 | $170 |
| Removal of gallbladder using an endoscope | 22 | $10,899 | $495 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $9,598 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 64 | $8,991 | $65 |
| New patient visit (45+ min) | 66 | $8,770 | $133 |
| New patient visit (30+ min) | 94 | $8,498 | $90 |
| Biopsy of large bowel using a flexible endoscope | 63 | $7,775 | $123 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 35 | $7,520 | $215 |
| Short return visit (20+ min) | 109 | $7,495 | $59 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 30 | $6,312 | $210 |
| Repair of groin hernia (5 years or older) | 13 | $5,966 | $459 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 22 | $4,632 | $211 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $4,154 | $115 |
| Return visit (30+ min) | 29 | $2,841 | $95 |
| Diagnostic exam of anus using an endoscope | 28 | $2,570 | $80 |
| Short return visit | 21 | $855 | $36 |
2017: 18 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $14,224 | $178 |
| Injection of hemorrhoid | 60 | $13,872 | $176 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $8,207 | $65 |
| New patient visit (30+ min) | 88 | $7,723 | $88 |
| New patient visit (45+ min) | 53 | $7,515 | $142 |
| Removal of gallbladder using an endoscope | 14 | $7,304 | $522 |
| Short return visit (20+ min) | 94 | $6,947 | $63 |
| Removal of external hemorrhoids by rubber banding | 13 | $6,465 | $259 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 25 | $5,246 | $210 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 23 | $4,877 | $212 |
| Biopsy of large bowel using a flexible endoscope | 41 | $4,740 | $116 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 19 | $3,929 | $207 |
| Diagnostic exam of anus using an endoscope | 36 | $2,715 | $73 |
| Return visit (30+ min) | 25 | $2,330 | $93 |
| Short return visit | 46 | $2,053 | $35 |
| Partial release of large bowel and partial removal of large bowel using an endoscope | 11 | $1,522 | $138 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,492 | $93 |
| New patient visit (15+ min) | 17 | $854 | $50 |
2016: 18 services
| Injection of hemorrhoid | 68 | $18,388 | $190 |
| Partial removal of small and large bowel with attachment of small and large bowel using an endoscope | 12 | $14,235 | $1,186 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $13,714 | $180 |
| Removal of gallbladder using an endoscope | 20 | $11,446 | $572 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 55 | $10,156 | $65 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 44 | $10,076 | $229 |
| New patient visit (30+ min) | 105 | $9,799 | $93 |
| Biopsy of large bowel using a flexible endoscope | 72 | $8,664 | $120 |
| Repair of groin hernia (5 years or older) | 15 | $7,269 | $485 |
| Removal of external hemorrhoids by rubber banding | 22 | $6,499 | $260 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 24 | $5,272 | $220 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 24 | $5,268 | $219 |
| New patient visit (45+ min) | 35 | $5,015 | $143 |
| Diagnostic exam of anus using an endoscope | 57 | $4,895 | $79 |
| Short return visit (20+ min) | 61 | $4,625 | $66 |
| Short return visit | 72 | $3,397 | $39 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,323 | $122 |
| New patient visit (15+ min) | 34 | $2,085 | $61 |
2015: 18 services
| Injection of hemorrhoid | 69 | $19,862 | $234 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 45 | $11,858 | $264 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $11,314 | $180 |
| New patient visit (30+ min) | 124 | $11,298 | $91 |
| Biopsy of large bowel using a flexible endoscope | 73 | $11,062 | $152 |
| Removal of gallbladder using an endoscope | 20 | $10,748 | $537 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 59 | $9,579 | $65 |
| Removal of external hemorrhoids by rubber banding | 16 | $7,480 | $267 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 29 | $6,795 | $234 |
| Short return visit (20+ min) | 82 | $6,020 | $60 |
| Repair of groin hernia (5 years or older) | 12 | $5,613 | $468 |
| New patient visit (45+ min) | 33 | $4,763 | $144 |
| Diagnostic exam of anus using an endoscope | 45 | $4,169 | $80 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,808 | $234 |
| Short return visit | 54 | $2,600 | $39 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $2,532 | $195 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,314 | $105 |
| New patient visit (15+ min) | 34 | $2,161 | $64 |
2014: 18 services
| Injection of hemorrhoid | 48 | $16,141 | $234 |
| Biopsy of large bowel using a flexible endoscope | 68 | $13,154 | $193 |
| New patient visit (30+ min) | 106 | $9,729 | $92 |
| Repair of groin hernia (5 years or older) | 16 | $7,420 | $464 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $7,397 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 57 | $6,773 | $113 |
| Removal of gallbladder using an endoscope | 12 | $6,194 | $516 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 23 | $6,170 | $268 |
| Short return visit (20+ min) | 80 | $6,143 | $60 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 24 | $5,821 | $243 |
| Diagnostic exam of anus using an endoscope | 49 | $4,522 | $78 |
| Diagnostic exam of large bowel using a flexible endoscope | 27 | $4,436 | $164 |
| Removal of external hemorrhoids by rubber banding | 13 | $3,496 | $233 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,433 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $2,692 | $93 |
| New patient visit (15+ min) | 32 | $2,051 | $64 |
| New patient visit (45+ min) | 15 | $1,934 | $129 |
| Short return visit | 35 | $1,598 | $40 |
2013: 15 services
| Partial removal of small and large bowel with attachment of small and large bowel using an endoscope | 13 | $14,227 | $1,094 |
| Injection of hemorrhoid | 50 | $14,093 | $243 |
| New patient visit (30+ min) | 151 | $13,268 | $88 |
| Biopsy of large bowel using a flexible endoscope | 50 | $10,027 | $201 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $8,340 | $86 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 32 | $8,170 | $255 |
| Removal of gallbladder using an endoscope | 15 | $8,102 | $540 |
| Short return visit (20+ min) | 103 | $8,067 | $57 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 28 | $6,805 | $243 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 46 | $5,946 | $117 |
| Diagnostic exam of large bowel using a flexible endoscope | 28 | $4,978 | $178 |
| Removal of external hemorrhoids by rubber banding | 12 | $4,303 | $253 |
| New patient visit (45+ min) | 25 | $3,495 | $140 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $3,115 | $62 |
| Diagnostic exam of anus using an endoscope | 33 | $2,925 | $79 |
Drugs they prescribed that Part D paid
$10,836
Pharmacies billed $10,836 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 10% of their Part D prescriptions (23 of 229) in 2024. At or below the middle of the specialty; the typical general surgery clinician is at 34%.
132 generic and 97 brand-name prescriptions · $10,836 in drug cost · 46 antibiotic prescriptions to 22 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Sod Sulf-Potass Sulf-Mag Sulf | 123 | $8,015 | $64 |
| Sutab | 14 | $2,268 | $162 |
| Hydrocodone-Acetaminophen | 16 | $54 | $3 |
| Neomycin Sulfate | 11 | $46 | $4 |
| Metronidazole | 12 | $31 | $2 |
Year by year
| 2024 | 229 | 179 | 10% (23) | 42% | $10,836 |
| 2023 | 299 | 216 | 7% (20) | 44% | $17,929 |
| 2022 | 286 | 208 | 9% (26) | 54% | $21,669 |
| 2021 | 299 | 219 | 4% (11) | 61% | $22,934 |
| 2020 | 267 | 190 | 8% (20) | 53% | $15,525 |
| 2019 | 316 | 219 | 6% (19) | 55% | $19,477 |
| 2018 | 357 | 229 | 6% (22) | 54% | $29,020 |
| 2017 | 320 | 213 | 10% (32) | None | $15,854 |
| 2016 | 239 | 181 | 13% (31) | 55% | $16,271 |
| 2015 | 268 | 217 | 11% (29) | 62% | $18,159 |
| 2014 | 316 | 215 | 14% (44) | 52% | $14,793 |
| 2013 | 244 | 193 | 13% (32) | 58% | $12,811 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Sod Sulf-Potass Sulf-Mag Sulf | 124 | $9,399 | $76 |
| Sutab | 31 | $5,248 | $169 |
| Neomycin Sulfate | 18 | $109 | $6 |
| Metronidazole | 27 | $95 | $4 |
| Hydrocodone-Acetaminophen | 16 | $64 | $4 |
2022: 5 drugs
| Suprep | 118 | $13,797 | $117 |
| Sutab | 26 | $4,255 | $164 |
| Neomycin Sulfate | 17 | $86 | $5 |
| Hydrocodone-Acetaminophen | 20 | $77 | $4 |
| Metronidazole | 22 | $70 | $3 |
2021: 3 drugs
| Suprep | 166 | $18,525 | $112 |
| Metronidazole | 23 | $122 | $5 |
| Neomycin Sulfate | 22 | $99 | $4 |
2020: 5 drugs
| Suprep | 134 | $14,078 | $105 |
| Amoxicillin-Clavulanate Potass | 13 | $241 | $19 |
| Metronidazole | 21 | $82 | $4 |
| Hydrocodone-Acetaminophen | 15 | $81 | $5 |
| Neomycin Sulfate | 14 | $74 | $5 |
2019: 4 drugs
| Suprep | 164 | $16,320 | $100 |
| Neomycin Sulfate | 21 | $119 | $6 |
| Metronidazole | 24 | $80 | $3 |
| Hydrocodone-Acetaminophen | 12 | $65 | $5 |
2018: 6 drugs
| Suprep | 168 | $15,765 | $94 |
| Proctozone-Hc | 16 | $630 | $39 |
| Neomycin Sulfate | 20 | $114 | $6 |
| Hydrocodone-Acetaminophen | 19 | $109 | $6 |
| Pantoprazole | 12 | $77 | $6 |
| Metronidazole | 22 | $65 | $3 |
2017: 8 drugs
| Suprep | 130 | $11,505 | $88 |
| Proctozone-Hc | 16 | $893 | $56 |
| Hydrocodone-Acetaminophen | 26 | $196 | $8 |
| Nitro-Bid | 11 | $171 | $16 |
| Metronidazole | 29 | $130 | $4 |
| Neomycin Sulfate | 19 | $119 | $6 |
| Ciprofloxacin | 11 | $67 | $6 |
| Cephalexin | 11 | $65 | $6 |
2016: 4 drugs
| Suprep | 128 | $10,615 | $83 |
| Hydrocodone-Acetaminophen | 23 | $282 | $12 |
| Neomycin Sulfate | 20 | $104 | $5 |
| Metronidazole | 24 | $82 | $3 |
2015: 3 drugs
| Suprep | 161 | $13,068 | $81 |
| Hydrocodone-Acetaminophen | 20 | $169 | $8 |
| Metronidazole | 17 | $56 | $3 |
2014: 6 drugs
| Suprep | 157 | $12,151 | $77 |
| Hydrocodone-Acetaminophen | 31 | $298 | $10 |
| Proctozone-Hc | 19 | $270 | $14 |
| Proctosol-Hc | 14 | $190 | $14 |
| Metronidazole | 23 | $158 | $7 |
| Ciprofloxacin | 15 | $101 | $7 |
2013: 4 drugs
| Suprep | 128 | $9,221 | $72 |
| Proctosol-Hc | 15 | $315 | $21 |
| Hydrocodone-Acetaminophen | 23 | $205 | $9 |
| Proctozone-Hc | 18 | $185 | $10 |
Money from drug and device companies
$278 in 2025
| 2025 | 6 | 7 | None | $278 |
| 2023 | 2 | 3 | None | $50 |
| 2022 | 3 | 3 | None | $49 |
| 2021 | 3 | 5 | None | $191 |
| 2020 | 2 | 10 | None | $1,532 |
| 2019 | 5 | 64 | None | $12,646 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| InSightec | Exablate | $147 | 1 payment
|
| Braintree Laboratories | Suflave | $38 | 2 payments
|
| Phathom Pharmaceuticals | Voquezna | $27 | 1 payment
|
| Stimlabs | Corplex P | $26 | 1 payment
|
| Ethicon | None | $22 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $19 | 1 payment
|
See all 7 published payments
| Phathom Pharmaceuticals | Meals · 2025-12-15 | Voquezna | $27 |
| InSightec | Meals · 2025-11-11 | Exablate | $147 |
| Stimlabs | Meals · 2025-10-28 | Corplex P | $26 |
| Braintree Laboratories | Meals · 2025-05-21 | Suflave | $20 |
| Ethicon | Meals · 2025-05-07 | None | $22 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-03 | Entyvio | $19 |
| Braintree Laboratories | Meals · 2025-01-15 | Sutab | $18 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $50
| Braintree Laboratories | Sutab | $35 | 2 payments
|
| Pacira Pharmaceuticals | Exparel | $15 | 1 payment
|
2022: $49
| Davol | Phasix Mesh | $19 | 1 payment
|
| Innocoll Pharmaceuticals | Xaracoll | $16 | 1 payment
|
| Braintree Laboratories | Sutab | $14 | 1 payment
|
2021: $191
| Intuitive Surgical | Da Vinci Surgical System | $149 | 3 payments
|
| Medtronic | Eea | $23 | 1 payment
|
| Olympus America | None | $18 | 1 payment
|
2020: $1,532
| Intuitive Surgical | Da Vinci Surgical System | $1,494 | 8 payments
|
| Davol | Phasix | $38 | 2 payments
|
2019: $12,646
| Intuitive Surgical | Da Vinci Surgical System | $12,277 | 60 payments
|
| Davol | Phasix | $222 | 1 payment
|
| Covidien LP | None | $109 | 1 payment
|
| AbbVie | Mavyret | $24 | 1 payment
|
| Braintree Laboratories | Motofen | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 86.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1447253380
- Licence
- CA G38707California G38707: Current · expires 2028-08-31
- Trained
- Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University, 1977
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G387070
- Taxonomy
- Federal specialty code 208C00000X (208C00000X)
- Mailing address
- 3838 California St, Rm 616, San Francisco, CA, 94118
- NPI first listed
- 2005-05-24
- NPI last updated
- 2008-06-05
This is when the NPI record was last certified, not a medical board exam.